The Multiple Sclerosis Center
The Multiple Sclerosis (MS) program
at the University of Pennsylvania Health
System provides comprehensive evaluation,
diagnosis and treatment for patients with
MS and other demyelinating disorders of
the central nervous system. In addition
to maintaining high standards for clinical
service, the Penn MS program is a leader
in MS training and in clinical and
laboratory-based research.
A Legacy of Hope
The MS program was originally established in 1980
to perform basic research to investigate the origin
and development of multiple sclerosis and to provide
specialty services for individuals who were burdened
with what was, at that time, an untreatable disease.
Since then, the program has trained many of the
leading MS clinicians and researchers throughout
the U.S. and internationally.
- As active and consistent participants in pivotal
MS treatment trials, faculty and staff in the MS
program have provided important contributions to
the development of immunomodulatory and other
forms of therapy.
- Neuroradiology and immunology research at Penn
is continuing to advance techniques and models of
disease to advance diagnosis and treatment.
- Researchers in MS and neuro-ophthalmology at
Penn are leading international collaborative efforts
to develop measures of visual function and axonal
loss through ocular imaging for use in ongoing and
future MS clinical trials. These studies have also
established the visual profile of MS as including
sub-clinical dysfunction not detectable by
conventional visual acuity testing.
For more information about our services, please
visit:
|
